Compound Danshen dripping pills prevent early diabetic retinopathy: roles of vascular protection and neuroprotection
Introduction: Diabetic retinopathy (DR) represents a major cause of adult blindness, and early discovery has led to significant increase in the number of patients with DR. The drugs currently used for treatment, such as ranibizumab, mainly focus on the middle and late periods of DR, and thus do not...
Saved in:
Main Authors: | Xiaoyu Xu (Author), Mengchen Wang (Author), Shuxia Zhang (Author), Jing Wang (Author), Xinxin Li (Author), Xiaohui Ma (Author), Yun Luo (Author), Xiaobo Sun (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-cell RNA sequencing in atherosclerosis: Mechanism and precision medicine
by: Qiaoyu Li, et al.
Published: (2022) -
Diabetic retinopathy: Involved cells, biomarkers, and treatments
by: Jiahui Ren, et al.
Published: (2022) -
Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
by: Shuxia Zhang, et al.
Published: (2021) -
Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
by: Le Liu, et al.
Published: (2022) -
Proangiogenesis effects of compound danshen dripping pills in zebrafish
by: Yang-Xi Hu, et al.
Published: (2022)